These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22365781)

  • 1. NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee.
    O'Reilly M; Shipp A; Rosenthal E; Jambou R; Shih T; Montgomery M; Gargiulo L; Patterson A; Corrigan-Curay J
    Methods Enzymol; 2012; 507():313-35. PubMed ID: 22365781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Institutes of Health system for enhancing the science, safety, and ethics of recombinant DNA research.
    Shipp AC; Patterson AP
    Comp Med; 2003 Apr; 53(2):159-64. PubMed ID: 12784849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 5. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector.
    Podsakoff GM
    Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility.
    Grilley BJ; Gee AP
    Cytotherapy; 2003; 5(3):197-207. PubMed ID: 12850787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology on the RAC--FDA/NIH regulation of human gene therapy.
    Rainsbury JM
    Food Drug Law J; 2000; 55(4):575-600. PubMed ID: 12025851
    [No Abstract]   [Full Text] [Related]  

  • 8. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of the National Institutes of Health Guidelines for Recombinant DNA Research.
    Talbot B
    Public Health Rep; 1983; 98(4):361-8. PubMed ID: 6611823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003.
    National Institutes of Health Recombinant DNA Advisory Committee
    Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant DNA research; proposed actions under guidelines. National Institutes of Health, PHS, DHHS.
    Moskowitz J
    Recomb DNA Tech Bull; 1989 Sep; 12(3):194-201. PubMed ID: 2595019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy. RAC's advice: proceed with caution.
    Kaiser J
    Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
    [No Abstract]   [Full Text] [Related]  

  • 13. Department of Health and Human Services, National Institutes of Health. Recombinant DNA research: proposed actions under the guidelines.
    Recomb DNA Tech Bull; 1990 Dec; 13(4):371-80. PubMed ID: 2093951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee.
    Beach JE
    Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560
    [No Abstract]   [Full Text] [Related]  

  • 15. Department of Health and Human Services, National Institutes of Health. Recombinant DNA research: proposed actions under the guidelines.
    Recomb DNA Tech Bull; 1990 Sep; 13(3):193-208. PubMed ID: 2270313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
    Dunbar CE; Emmons RV
    Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy: proceed with caution.
    Grobstein C; Flower M
    Hastings Cent Rep; 1984 Apr; 14(2):13-7. PubMed ID: 6373668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Human Gene Therapy Subcommittee. Minutes of meeting, December 9, 1988.
    Recomb DNA Tech Bull; 1989 Mar; 12(1):29-45. PubMed ID: 2657876
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant DNA research; proposed actions under guidelines. National Institutes of Health.
    Recomb DNA Tech Bull; 1987 Sep; 10(3):90-104. PubMed ID: 3685453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical study design for rAAV.
    Flotte TR; Conlon TJ; Mueller C
    Methods Mol Biol; 2011; 807():317-37. PubMed ID: 22034037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.